SHE:300534 - Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

Gansu Longshenrongfa Pharmaceu
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2011 Q4	2012 Q4	2013 Q4	2014 Q4	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	267.09M 4.2%	253.65M -5.0%	287.81M 13.5%	293.92M 2.1%	330.51M 12.4%	344.62M 4.3%	413.25M 19.9%	592.68M 43.4%	728.25M 22.9%	824.45M 13.2%	1.08B 31.0%	1.04B -3.8%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	177.53M 2.0%	170.2M -4.1%	195.42M 14.8%	192.46M -1.5%	206.12M 7.1%	210.9M 2.3%	249.52M 18.3%	302.17M 21.1%	321.87M 6.5%	335.25M 4.2%	386.23M 15.2%	350.81M -9.2%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	89.56M 8.9%	83.44M -6.8%	92.39M 10.7%	101.46M 9.8%	124.39M 22.6%	133.72M 7.5%	163.72M 22.4%	290.51M 77.4%	406.37M 39.9%	489.2M 20.4%	693.82M 41.8%	687.83M -0.9%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	256.78M 1.6%	253.31M -1.4%	292.96M 15.7%	298.86M 2.0%	328.15M 9.8%	330.54M 0.7%	383.35M 16.0%	532.04M 38.8%	652.09M 22.6%	734.13M 12.6%	978.73M 33.3%	935.44M -4.4%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	79.25M 0.5%	83.11M 4.9%	97.54M 17.4%	106.4M 9.1%	122.03M 14.7%	119.63M -2.0%	133.83M 11.9%	229.87M 71.8%	330.22M 43.7%	398.88M 20.8%	592.5M 48.5%	584.62M -1.3%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	10.31M 201.5%	335.45K -96.7%	-5.15M -	-4.94M -	2.36M -	14.09M 496.6%	29.89M 112.2%	60.64M 102.9%	76.16M 25.6%	90.31M 18.6%	101.32M 12.2%	103.2M 1.9%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	13.93M -	-	-6.3M -	-	-2.56M -	-	30.3M -	-	61.87M -	-	83.85M -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	12.67M 598.5%	6.4M -49.4%	-9.11M -	-8.69M -	-7.44M -	4.53M -	25.83M 470.2%	42.81M 65.8%	49.62M 15.9%	56.63M 14.1%	61.65M 8.9%	63.78M 3.5%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.042 606.8%	0.021 -49.4%	-0.03 -	-0.029 -	-0.025 -	0.015 -	0.085 467.3%	0.141 65.7%	0.164 16.0%	0.187 14.2%	0.203 8.8%	0.21 3.5%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.042 606.8%	0.021 -49.4%	-0.03 -	-0.029 -	-0.025 -	0.015 -	0.085 467.3%	0.141 65.7%	0.164 16.0%	0.187 14.2%	0.203 8.8%	0.21 3.5%